The density of CSF-1R+ TAMs in tumors correlates with poor outcomes in many tumor types, including colon adenocarcinoma, pancreatic cancer, classical Hodgkin lymphoma, leiomyosarcoma, hepatocellular carcinoma and breast cancer (81–86). The gene discussed is CSF1R; the disease is hepatocellular carcinoma.